fashion -WSS

fashion

author：Wikipedia 2025-09-06 01:58:40 - browse：71431

Illlustration of a giant computer screen surrounded by people and text bubbles with question marks for story on Chat GPT – AI and health tech coverage from STAT — Mike Reddy for STAT

Artificial intelligence is often described as a black box: an unknowable, mysterious force that operates inside the critical world of health care. If it’s hard for experts to wrap their heads around at times, it’s almost impossible for patients or the general public to grasp.

While AI-powered tools like ChatGPT are swiftly gaining steam in medicine, patients rarely have any say — or even any insight — into how these powerful technologies are being used in their own care.

To get a handle on the most pressing concerns among patients, STAT asked our readers what they most wanted to know about generative AI’s use in medicine. Their submissions ranged from fundamental questions about how the technology works to concerns about bias and error creeping further into our health systems.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Peter Hotez and the public health issue of online harassment
Next article： STAT Summit: Doctor v. ChatGPT showed AI's promise, blind spots

knowledge

WSS

EPA limits use of carcinogenic gas for sterilizing medical devices

CZI to create biohub to build anti

President Biden's budget: Here's what you might have missed

President Biden's budget: Here's what you might have missed

President Biden's budget: Here's what you might have missed

Merck, Daiichi strike cancer drug pact worth up to $22 billion

explore

fashion

Wikipedia

Medicare details structure of new drug price negotiation program

How to save health care price transparency rules

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

President Biden's budget: Here's what you might have missed

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Acadia's Nuplazid fails as schizophrenia medicine in Phase 3 study

BioMarin wins approval for gene therapy to treat hemophilia A

Ebola: Gilead Sciences antiviral shows promise as new treatment

Duchenne breakthrough therapy leaves behind pioneering families

STAT Summit: How researchers deal with rejection

hotspot

CZI to create biohub to build anti

Readout Newsletter: AstraZeneca's CEO, Roivant's $5 billion deal

John Green on his newest strategy for fighting tuberculosis

How to save health care price transparency rules

Is there really a nursing shortage in the U.S.?

CZI to create biohub to build anti

hotspot

knowledge

knowledge

leisure time